ArisGlobal has launched TotalSafety 7.3, the latest enhancement to its comprehensive safety suite, the company said.
Building upon industry-leading best practices, the fully cloud- and Single Application Instance (SAI)-based platform continues to meet the compliance requirements stipulated in the most recent pharmacovigilance and device vigilance regulations, while incorporating innovative technical and functional improvements.
ArisGlobal´s cloud-based solutions facilitate global drug development and regulatory compliance within the life sciences and healthcare industries. Its cloud platform supports the entire product life cycle including clinical development, regulatory affairs, pharmacovigilance and medical communications.
Headquartered in the United States, ArisGlobal has regional offices in Europe, India and Japan.